Found: 15
Select item for more details and to access through your institution.
NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson's disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
RS-127445: a selective, high affinity, orally bioavailable 5-HT<sub>2B</sub> receptor antagonist.
- Published in:
- British Journal of Pharmacology, 1999, v. 127, n. 5, p. 1075, doi. 10.1038/sj.bjp.0702632
- By:
- Publication type:
- Article
Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine- β-hydroxylase.
- Published in:
- British Journal of Pharmacology, 1997, v. 121, n. 8, p. 1803, doi. 10.1038/sj.bjp.0701315
- By:
- Publication type:
- Article
Alzheimer's disease psychosis: Potential therapeutic benefit of pimavanserin, a 5-HT<sub>2A</sub> inverse agonist
- Published in:
- 2010
- By:
- Publication type:
- Abstract
P1-013: Antipsychotic-like activity of pimavanserin, A 5-ht<sub>2a</sub> inverse agonist, in putative animal models of Alzheimer's disease psychosis
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, p. 1, doi. 10.1038/s41531-024-00658-6
- By:
- Publication type:
- Article
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00552-7
- By:
- Publication type:
- Article
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
- Published in:
- Psychopharmacology, 2003, v. 165, n. 2, p. 128, doi. 10.1007/s00213-002-1240-x
- By:
- Publication type:
- Article
In Vitro pharmacology of N-desmethylclozapine (ACP-104) as compared to other atypical antipsychotic agents.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A787, doi. 10.1096/fasebj.21.6.a787
- By:
- Publication type:
- Article
Cloning and Expression of a 5-Hydroxytryptamine<sub>7</sub> Receptor Positively Coupled to Adenylyl Cyclase.
- Published in:
- Journal of Neurochemistry, 1994, v. 63, n. 2, p. 456, doi. 10.1046/j.1471-4159.1994.63020456.x
- By:
- Publication type:
- Article
Pharmacological Characterization of 5-Hydroxytryptamine<sub>3</sub>Receptors in Murine Brain and Ileum Using the Novel Radioligand [<sup>3</sup>H]RS-42358-197: Evidence for Receptor Heterogeneity.
- Published in:
- Journal of Neurochemistry, 1993, v. 61, n. 5, p. 1927, doi. 10.1111/j.1471-4159.1993.tb09835.x
- By:
- Publication type:
- Article
Labelling of 5-Hydroxytryptamine<sub>3</sub> Receptors with a Novel 5-HT<sub>3</sub> Receptor Ligand, [<sup>3</sup>H]RS-42358-197.
- Published in:
- Journal of Neurochemistry, 1993, v. 60, n. 3, p. 921, doi. 10.1111/j.1471-4159.1993.tb03238.x
- By:
- Publication type:
- Article
NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation.
- Published in:
- International Journal of Inflammation, 2022, p. 1, doi. 10.1155/2022/2337363
- By:
- Publication type:
- Article
Novel approach to studying N-methyl-D-aspartate receptor function in the kindling model of epilepsy.
- Published in:
- Drug Development Research, 1989, v. 17, n. 4, p. 321, doi. 10.1002/ddr.430170407
- By:
- Publication type:
- Article
Enhanced delayed matching performance in younger and older macaques administered the 5-HT[sub 4] receptor agonist, RS 17017.
- Published in:
- Psychopharmacology, 1998, v. 135, n. 4, p. 407, doi. 10.1007/s002130050529
- By:
- Publication type:
- Article